Am J Transplant, Volume 18, Suppl 3 Archives - Page 121 of 211 - ATC Abstracts

2018 American Transplant Congress
Do Recent Heart Transplant Patients Need to Reside Close to the Transplanting Center? A Look at the Impact of Commuting Times on Clinical Outcomes
A. Velleca, E. Kransdorf, J. Patel, M. Kittleson, S. Dimbil, R. Levine, D. Geft, D. Chang, L. Czer, J. Kobashigawa.
Cedars Sinai Medical Center, Los Angeles.
Purpose: Compliance after heart transplantation (HTx) is crucial to ensure adequate drug dosing and avoidance of complications especially within the first six months. To ensure…
2018 American Transplant Congress
A Population Based Study of Incidence of Post Kidney Transplant Malignancies
D. Sexton,¹ J. O'Neill,² P. O'Kelly,¹ S. Murray,¹ S. Deady,³ E. O'Leary,³ P. Morris,⁴ P. Conlon.¹
¹Department of Nephrology & Transplantation, Beaumont Hospital Dublin, Royal College of Surgeons Ireland, Dublin, Ireland; ²Department of Otolaryngology, Head and Neck Surgery, Beaumont Hospital, Dublin, Ireland; ³National Cancer Registry Ireland, Cork, Ireland; ⁴Department of Oncology, Beaumont Hospital, Dublin, Ireland.
IntroductionWe aimed to report national standardised incidence for malignancy post transplant compared to the general population stratified by solid organ categories. In this study we…
2018 American Transplant Congress
Molecular Assessment of Post-Transplant Glomerular Disease Comparing to Transplant Glomerulopathy
E. Akalin,¹ M. e Silva,² Y. Bao,¹ V. Bontha,³ M. Ajaimy,¹ V. Mas,³ P. [Oacute] Broin.²
¹Montefiore Medical Center, Bronx, NY; ²National University of Ireland Galway, Galway, Ireland; ³University of Virginia, Charlottesville.
Background: Intragraft gene expression profiles of glomerular disease after kidney transplantation has not been well described other than transplant glomerulopathy (TGP) which develops due to…
2018 American Transplant Congress
Differential Effects of Inhibiting Glycolysis on Human Treg Subsets
N. Tanimine, B. Priyadharshini, S. Germana, L. Turka.
Department of Surgery, Massachusetts General Hospital, Boston, MA.
Regulatory T cells (Tregs) are a promising therapeutic tool for inducing transplantation tolerance. Tregs can be divided into those of thymic origin (tTreg) and those…
2018 American Transplant Congress
Variation in Post-Transplant Opiate Prescribing Patterns across Transplant Centers
A. Mathur, D. Ubl, J. Harbell, K. Croome, C. Taner, J. Heimbach, A. Moss, E. Habermann.
Mayo Clinic, Rochester, Phoenix, Jacksonville.
Background: Excess opiate prescribing has led to an epidemic, and evidence to guide abdominal transplant practice is lacking. We aimed to identify variation in opiate…
2018 American Transplant Congress
Humoral Immune Response to Seasonal Influenza Infection in Transplant Recipients
C. Hirzel,¹ V. Ferreira,¹ A. L'Huillier,¹ K. Hoschler,² E. Cordero,³ G. Reid,⁴ J. Englund,⁵ A. Limaye,⁶ A. Humar,¹ D. Kumar.¹
¹UHN, Toronto, Canada; ²Public Health England, London, United Kingdom; ³REIPI, Sevilla, Spain; ⁴LUMC, Chicago; ⁵SCH, Seattle; ⁶UOWMC, Seattle.
Background: Little is known about the serologic response to natural influenza infection in transplant recipients. We describe the hemagglutinin antibody response to influenza A/H1N1 infection…
2018 American Transplant Congress
Thrombotic Microangiopathy after Renal Transplantation: A Clinicopathological Study and Identification of Prognostic Factors
K. Dessaix,¹ C. Bontoux,² O. Aubert,¹ J. Zuber,¹ R. Sberro Soussan,¹ V. Frémeaux-Bacchi,³ M. Le Quintrec,⁴ C. Legendre,¹ M. Rabant.²
¹Renal Transplantation Department, Necker-Enfants Malades Hospital, Paris, France; ²Pathology Department, Necker-Enfants Malades Hospital, Paris, France; ³Immunology Laboratory, Georges Pompidou European Hospital, Paris, France; ⁴Nephrology Department, CHU Montpellier, Montpellier, France.
IntroductionThrombotic microangiopathy (TMA), whether de novo or recurrent, is a serious complication after renal transplantation, but prognostic factors and the role of complement inhibitors in…
2018 American Transplant Congress
Familial Risk of End-Stage Renal Disease in Healthy Live Kidney Donors
A. Muzaale,¹ A. Massie,¹ F. Al Ammary,¹ K. Lentine,² D. Segev.¹
¹Johns Hopkins University, Baltimore; ²Saint Louis University, St. Louis.
Kidney donor candidates are rigorously evaluated so that only the lowest risk are cleared for donation; however, it is not standard practice to exclude candidates…
2018 American Transplant Congress
Impact of the Differences between Body Mass Index of Recipient and Donor in a Population of Robotic Kidney Transplant
K. Tulla,¹ I. Tzvetanov,¹ C. Di Bella,¹ F. Gheza,¹ M. Spaggiari,¹ J. Oberholzer,² E. Benedetti.¹
¹Surgery, University of Illinois, Chicago, IL; ²Surgery, Universit of Virginia, Virginia, VA.
Introduction: The recent introduction of minimally invasive technique allows to perform kidney transplant in otherwise suitable recipients regardless the recipient BMI. This could lead to…
2018 American Transplant Congress
Should More Donation after Cardiac Death Livers Be Used in Pediatric Transplantation?
C. Hwang,¹ S. Levea,² M. MacConmara.¹
¹Surgery, UT Southwestern Medical Center, Dallas, TX; ²Medicine, UT Southwestern Medical Center, Dallas, TX.
Introduction: Multiple strategies exist to increase the organ pool for livers in pediatric recipients, including using split livers, high risk livers, and donation after cardiac…